Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor.
暂无分享,去创建一个
[1] K. Nakajima,et al. Remnant Lipoprotein-Induced Smooth Muscle Cell Proliferation Involves Epidermal Growth Factor Receptor Transactivation , 2003, Circulation.
[2] H. Pijl,et al. Rosiglitazone improves muscle insulin sensitivity, irrespective of increased triglyceride content, in ob/ob mice. , 2003, Metabolism: clinical and experimental.
[3] M. Matsuda,et al. Angiopoietin-like Protein 3 Mediates Hypertriglyceridemia Induced by the Liver X Receptor* , 2003, Journal of Biological Chemistry.
[4] M. Shimamura,et al. A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice Published, JLR Papers in Press, April 2, 2003. DOI 10.1194/jlr.M300031-JLR200 , 2003, Journal of Lipid Research.
[5] M. Matsuda,et al. Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. , 2003, Biochemical and biophysical research communications.
[6] Theresa Zhang,et al. Regulation of the angiopoietin-like protein 3 gene by LXR Published, JLR Papers in Press, October 16, 2002. DOI 10.1194/jlr.M200367-JLR200 , 2003, Journal of Lipid Research.
[7] Kenichi Yoshida,et al. ANGPTL3 Decreases Very Low Density Lipoprotein Triglyceride Clearance by Inhibition of Lipoprotein Lipase* , 2002, The Journal of Biological Chemistry.
[8] G. Camenisch,et al. ANGPTL3 Stimulates Endothelial Cell Adhesion and Migration via Integrin αvβ3 and Induces Blood Vessel Formation in Vivo * , 2002, The Journal of Biological Chemistry.
[9] T. Fujiwara,et al. Angptl3 regulates lipid metabolism in mice , 2002, Nature Genetics.
[10] G. Reaven. Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia , 2002, Diabetes, obesity & metabolism.
[11] D. Capuzzi,et al. Lipid disorders in type 1 and type 2 diabetes. , 2001, Clinics in laboratory medicine.
[12] P. Cullen. Evidence that triglycerides are an independent coronary heart disease risk factor. , 2000, The American journal of cardiology.
[13] M. Gibney,et al. The Impact of Postprandial Lipemia in Accelerating Atherothrombosis , 2000, Journal of cardiovascular risk.
[14] Y. Iwamoto,et al. Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. , 2000, Diabetes care.
[15] H. Ginsberg. Insulin resistance and cardiovascular disease. , 2000, The Journal of clinical investigation.
[16] S. Wattler,et al. Identification of a mammalian angiopoietin-related protein expressed specifically in liver. , 1999, Genomics.
[17] S. Phaneuf,et al. Bromocriptine/SKF38393 treatment ameliorates dyslipidemia in ob/ob mice. , 1999, Metabolism: clinical and experimental.
[18] P. Elwood,et al. Triglyceride as a risk factor for ischaemic heart disease in British men: effect of adjusting for measurement error. , 1999, Atherosclerosis.
[19] R. Evans,et al. Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.
[20] L. Tartaglia,et al. Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.
[21] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.
[22] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[23] T. Yoshioka,et al. Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice. , 1991, Metabolism: clinical and experimental.
[24] A. Hamsten,et al. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. , 1990, Arteriosclerosis.
[25] J. McGarry. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. , 2002, Diabetes.
[26] R. Unger. Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0870 Minireview: Weapons of Lean Body Mass Destruction: The Role of Ectopic Lipids in the Metabolic Syndrome , 2022 .